Biography: Dr Tim M Williams
Is Clinical Director of specialist drug and alcohol services in for AWP NHS Trust in the South West. He is an Honaray Senior Clinical Lecturer at the University of Bristol. He is involved in many clincial and research interests including alcohol use, new psychoactive substances, and neuroimaging.
He is a memeber of the Independent Scientfic Committee on Drugs and recently project Neptune looking at harms from emerging new psychoactive substances. He has written three risk assessment documents for the Advisory Council for the Misuse of Drugs and can be regualrly found on various media outlets.
Conflicts of Interests: None
Raeding List:
Nutt DJ, King LA, Phillips LD; Independent Scientific Committee on Drugs. Drug harms in the UK: a multicriteria decision analysis. Lancet. 2010 Nov 6;376(9752):1558-65.
Lingford-Hughes et al. BAP guidelines. J Psychopharmacol. 2012 Jul;26(7):899-952
NICE (2010) Alcohol-Use Disorders: Preventing the Development of Hazardous and Harmful Drinking. NICE public health guideline PH24
NICE (2010) Alcohol Use Disorders: Diagnosis and Clinical Management of Alcohol- Related Physical Complications. NICE clinical guideline CG100
NICE (2011) Alcohol Use Disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence. NICE clinical guideline CG115
Addolorato G, Leggio L, Agabio R, Colombo G, Gasbarrini G. Baclofen: a new drug for the treatment of alcohol dependence. Int J Clin Pract. 2006 Aug;60(8):1003-8
Degenhardt L, Randall D, Hall W, Law M, Butler T, Burns L. Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved. Drug Alcohol Depend. 2009 Nov 1;105(1-2):9-15.
Cornish, Macleod , Strang, Vickerman , Hickman. Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database BMJ. 2010 Oct 26;341
Mattick et al, Cochrane Database Syst Rev. 2008;(2):CD002207
Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Martin SF, Yazar-Klosinski B, Michel Y, Brewerton TD, Doblin R. Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study. J Psychopharmacol. 2013 Jan;27(1):28-39.